Yang Zhuoshi, Zhao Na, Li Jinchuang, Wu Zhouxin, Ma Jian
First School of Clinical Medicine, Heilongjiang University of Chinese Medicine, Harbin, China.
Endocrinology Department 1, The First Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine, Harbin, China.
Front Pharmacol. 2024 Aug 22;15:1411459. doi: 10.3389/fphar.2024.1411459. eCollection 2024.
Graves' disease (GD) is the most common cause of hyperthyroidism and can affect multiple systems of the body. Currently, commonly-used treatment methods for GD have a series of shortcomings. In contrast, traditional Chinese medicine has been proven to be effective in inhibiting the progression of GD and is expected to become a key direction for the development of new drugs in the future. Therefore, a network meta-analysis was performed to compare the impacts of different traditional Chinese medicines on the curative effect, thyroid-stimulating hormone (TSH), free triiodothyronine (FT3), free thyroxine (FT4), thyroglobulin antibody (TGAb), thyroid peroxidase antibody (TPOAb) and thyrotropin receptor antibody (TRAb) in patients with GD. PubMed, Embase, Cochrane Library, Web of Science, WanFang, Weipu, and CNKI were searched for the randomized controlled trials of traditional Chinese medicine on GD patients up to 19 December 2023. The quality of the included studies was evaluated regarding the risk of bias, and the data were analyzed by R software. Thirty-five articles were included in the analysis, involving 2828 GD patients and traditional Chinese medicines including Bailing Capsule, Jinshuibao Capsule, Astragalus injection, Jiakangling Tablet, Jiakangling Capsule, Tripterygium Wilfordii, Sanjie Xiaoying Decoction, Oral Liquid, Granules, Xiehuo Xiaoying Recipe, Xiehuo Yangyin Powder, Yikang Pill and Yinjia Pellet. The results of network meta-analysis suggested that for GD patients, Bailing Capsule, Jiakangling Capsule, Tripterygium wilfordii, Oral Liquid and Yinjia Pellet had better curative effect compared with Western medicine. Granules and Yikang Pill could improve the TSH level. Granules, Oral Liquid and Yikang Pill could reduce FT3 level. Jiakangling Capsule, Granules, Oral Liquid and Yikang Pill could reduce the FT4 level. Oral Liquid can reduce the level of TPOAb and TRAb. Besides, Yinjia Pellet was the most helpful in improving the curative effect. Yikang Pill could best improve TSH. Granules had the best effect on reducing FT3. Granules performed best in reducing FT4. Oral Liquid had the most favorable effect on reducing TPOAb and TRAb. Based on the current research, it is safe to conclude that Chinese medicine can improve the curative effect and TSH level of patients with GD, and reduce the levels of FT3, FT4, TPOAb and TRAb. Besides, Yinjia Pellet is the most helpful in improving the curative effect. Yikang Pill can best improve TSH. Granules have the best effect on reducing FT3. Granules perform best in reducing FT4. Oral Liquid has the most favorable effect on reducing TPOAb and TRAb. https://www.crd.york.ac.uk/PROSPERO/#recordDetails, identifier CRD42024521912.
格雷夫斯病(GD)是甲状腺功能亢进最常见的病因,可累及身体多个系统。目前,GD常用的治疗方法存在一系列缺点。相比之下,传统中药已被证明在抑制GD进展方面有效,有望成为未来新药研发的关键方向。因此,进行了一项网状Meta分析,以比较不同中药对GD患者疗效、促甲状腺激素(TSH)、游离三碘甲状腺原氨酸(FT3)、游离甲状腺素(FT4)、甲状腺球蛋白抗体(TGAb)、甲状腺过氧化物酶抗体(TPOAb)和促甲状腺激素受体抗体(TRAb)的影响。检索了PubMed、Embase、Cochrane图书馆、科学网、万方、维普和知网,以查找截至2023年12月19日关于中药治疗GD患者的随机对照试验。根据偏倚风险评估纳入研究的质量,并使用R软件进行数据分析。分析纳入35篇文章,涉及2828例GD患者和包括百令胶囊、金水宝胶囊、黄芪注射液、甲亢灵片、甲亢灵胶囊、雷公藤、散结消瘿汤、口服液、颗粒剂、泻火消瘿方、泻火养阴散、抑亢丸和瘿甲丸在内的中药。网状Meta分析结果表明,对于GD患者,百令胶囊、甲亢灵胶囊、雷公藤、口服液和瘿甲丸与西药相比疗效更好。颗粒剂和抑亢丸可提高TSH水平。颗粒剂、口服液和抑亢丸可降低FT3水平。甲亢灵胶囊、颗粒剂、口服液和抑亢丸可降低FT4水平。口服液可降低TPOAb和TRAb水平。此外,瘿甲丸对提高疗效最有帮助。抑亢丸改善TSH效果最佳。颗粒剂降低FT3效果最佳。颗粒剂降低FT4效果最佳。口服液降低TPOAb和TRAb效果最佳。基于目前的研究,可以有把握地得出结论,中药可提高GD患者的疗效和TSH水平,并降低FT3、FT4、TPOAb和TRAb水平。此外,瘿甲丸对提高疗效最有帮助。抑亢丸改善TSH效果最佳。颗粒剂降低FT3效果最佳。颗粒剂降低FT4效果最佳。口服液降低TPOAb和TRAb效果最佳。https://www.crd.york.ac.uk/PROSPERO/#recordDetails,标识符CRD4^{2}024521912 。